Liminatus Pharma Says Common Stock Transferred To Nasdaq Capital Market Effective August 4; Nasdaq Panel Grants Extension Until September 3 To Regain Minimum Bid Price Compliance

Benzinga Newsdesk www.benzinga.com Positive 84.1%

Neg 0% Neu 0% Pos 84.1%

Comments

No comments yet. Be the first!